CHELSEA NEWEY: Open Payments
NPI 1235867177 · LITTLE ROCK, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,847 in 88 payments from 18 companies in 2025. Trend: 2023 $3,117 · 2024 $2,301 · 2025 $1,847
Food & beverage: $1,757Education: $90
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 13 | $291 |
| Novartis Pharmaceuticals Corporation | 12 | $256 |
| Lilly USA, LLC | 14 | $240 |
| Regeneron Healthcare Solutions, Inc. | 8 | $202 |
| Galderma Laboratories, L.P. | 6 | $142 |
| LEO Pharma Inc. | 5 | $104 |
| ABBVIE INC. | 5 | $92 |
| PFIZER INC. | 5 | $85 |
| GENZYME CORPORATION | 3 | $78 |
| UCB, Inc. | 4 | $75 |
Products named: TREMFYA, DUPIXENT, TALTZ, COSENTYX, NEMLUVIO, SKYRIZI, Bimzelx, Rhapsido.
Industry payments across AR — which companies pay providers there.
